Form 4: Quoin Pharmaceuticals Director Dennis Langer Reports Share Sale

Director Dennis Langer reported the sale of 297 ordinary shares of Quoin Pharmaceuticals, represented by American Depositary Shares (ADSs), at a price of $0.732 on June 7, 2024.

Summary

• On June 7, 2024, Dennis Langer, a director of Quoin Pharmaceuticals, Ltd., sold 297 ordinary shares of the company.
• The shares were sold at a price of $0.732 per share.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.
• The reported securities are represented by American Depositary Shares (ADSs), with each ADS representing one ordinary share of the Issuer.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing reporting a share sale by a director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders, providing transparency into their transactions in the company's stock. The sale by a director may be interpreted in various ways by the market, but without additional context, it's difficult to assess the specific implications.

Stakeholder Impact

• The sale of shares by a director could potentially influence investor sentiment, although the impact of a small transaction like this is likely to be minimal.

Key Dates

Keywords

Form 4, Quoin Pharmaceuticals, Dennis Langer, Share Sale, ADS, Director, QNRX